Johnson & Johnson (JNJ) Stock Forecast
US · Healthcare
Current price
$244.88
Market cap
$589.48B
Mean price target
$257.32
Implied upside
5.1%
Key takeaways
- Analysts rate Johnson & Johnson a “Buy”, with a mean price target of $257.32 — about 5.1% upside from the current $244.88, based on 22 analysts.
- JNJ is trading near its 52-week high, at 93% of the $151.01–$251.71 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 22 |
| Mean target | $257.32 |
| High target | $285.00 |
| Low target | $190.00 |
| Rating split (SB / B / H / S / SS) | 5 / 9 / 10 / 0 / 1 |
Price & trading
| Current price | $244.88 |
|---|---|
| Previous close | $241.00 |
| 52-week high | $251.71 |
| 52-week low | $151.01 |
| 50-day average | $230.24 |
| Beta | 0.26 |
See the full JNJ breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Johnson & Johnson (JNJ) share price?
- Johnson & Johnson last traded at $244.88 with a market capitalisation of about $589.5B.
- What is the analyst price target for JNJ?
- The mean analyst price target for Johnson & Johnson is $257.32, roughly 5.1% above the latest price. The current consensus rating is “Buy”.
- Where can I see Johnson & Johnson's full financial metrics?
- Luminoso tracks JNJ's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.